EYPT
Eyepoint Pharmaceuticals Inc
4.00$
+15.7%
vs. previous close
Closing price · As of: Sep 17, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 45.5% | 54.1% | 918.5% | 214.6% | 315.9% | 13.2% | 16.9% | 22.1% | 20.1% | 10.1% | 8.6% | 6.6% | |
| 54.5% | 100.0% | 100.0% | 100.0% | -237.9% | 86.8% | 83.1% | 77.9% | 79.9% | 89.9% | 91.4% | 93.4% | |
| 36.0% | 45.5% | 887.7% | 197.4% | 355.6% | 75.5% | 50.6% | 77.2% | 119.9% | 140.5% | 307.2% | 704.6% | |
| 28.1% | 30.3% | 556.4% | 149.0% | 263.0% | 88.1% | 60.2% | 69.2% | 84.1% | 87.1% | 121.0% | 164.5% | |
| 30.3% | 75.8% | 1,444.1% | 346.4% | 893.5% | 321.8% | 191.4% | 227.5% | 320.5% | 253.1% | 428.5% | 869.4% | |
| 24.2% | 24.2% | -1,344.1% | -246.4% | -838.8% | -235.0% | -108.3% | -149.6% | -240.6% | -163.1% | -337.1% | -776.0% | |
| 0.0% | 0.0% | 0.0% | 9.6% | 12.3% | 30.3% | 21.1% | 14.9% | 7.7% | 2.7% | 0.0% | 0.1% | |
| 24.3% | 24.3% | -1,339.6% | -245.2% | -1,527.3% | -278.9% | -131.8% | -158.1% | -247.0% | -153.7% | -302.2% | -738.5% | |
| 0.4% | 0.4% | -9.6% | -10.8% | -436.4% | 30.3% | 21.1% | 14.9% | 53.8% | 0.2% | 0.2% | 0.9% | |
| 23.9% | 23.9% | -1,330.1% | -245.2% | -908.0% | -278.9% | -131.8% | -158.1% | -247.0% | -153.8% | -302.4% | -739.4% | |
| 27.5% | 27.5% | -1,288.0% | -235.6% | -793.5% | -235.8% | -103.1% | -135.8% | -233.4% | -149.9% | -298.6% | -731.1% |
Data as of: September 17, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.